Ketamine or Esketamine in Special Populations of Patients With Treatment-Resistant Depression - PubMed

Conventional antidepressant drugs are effective in only approximately 50% of patients with treatment-resistant depression (TRD). Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, offers a promising alternative with an exceptionally rapid antidepressant effect. Although its effica …